Omada Health (OMDA) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for OMDA is $24.80, representing a +99.0% upside from the current price of $12.46. Price targets range from a low of $17.00 to a high of $32.00.